Sort
64,565 grants matching “drug discovery”
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2024 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2022 · DK
Cincinnati Cooperative Center of Excellence in Hematology
$852,127Yi Zheng · Cincinnati Childrens Hosp Med Ctr · U54 · FY2021 · DK
Endothelialized microfluidic assays for emerging therapies in sickle cell disease
$852,121Chiara Federici · Biochip Labs, Inc. · R42 · FY2022 · HL
Immunobiology of Acute Environmental Asthma
$852,000David B Peden · Univ Of North Carolina Chapel Hill · U19 · FY2009 · AI
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$851,913James M Olson · Seattle Children'S Hospital · U01 · FY2025 · CA
Preclinical drug development of isoform selective JNK3 inhibitors for Alzheimer's disease.
$851,900Sung Ok Yoon · Ohio State University · R01 · FY2017 · AG
Validating targets in p. aeruginosa type III secretion using chemical probes
$851,764Donald T Moir · Microbiotix, Inc · R01 · FY2014 · AI
Drug Discovery & Synthesis of Contraceptive Agents
$851,746Gunda I. Georg · University Of Minnesota · U01 · FY2014 · HD
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
$851,505Lutz Tautz · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · AG
Development of an acoustofluidic device for high-throughput 3D imaging and sorting of C. elegans
$851,323Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2022 · OD
Development of an acoustofluidic device for high-throughput 3D imaging and sorting of C. elegans
$851,323Lin Wang · Ascent Bio-Nano Technologies, Inc. · R44 · FY2023 · OD
Nuclear Receptor Control of T Cell Function in Discrete Intestinal Microenvironments
$851,173Mark Scott Sundrud · Dartmouth-Hitchcock Clinic · R01 · FY2023 · AI
Optimization of Drug-like Properties of CRFBP-CRF2 Negative Allosteric Modulators for Alcohol Use Disorder
$851,142Douglas J Sheffler · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2023 · AA
Admin-Core
$851,080Alan D. Palkowitz · Indiana University Indianapolis · U54 · FY2025 · AG
RNA Targeted Drug Discovery and Development for Parkinson Disease
$851,067M. Maral Mouradian · Rbhs-Robert Wood Johnson Medical School · UH3 · FY2021 · NS
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase
$851,030Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2019 · AI
Structural Analysis and Inhibitor Optimization of Cryptosporidium n-myristoyltransferase for Drug Discovery
$850,984Bart Lee Staker · Seattle Children'S Hospital · R01 · FY2021 · AI
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$850,957Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2022 · CA
UIC: In vitro In vivo Mtb Pharmacology
$850,917Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease
$850,917Eric Joseph Rubin · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
Scientific Core - Compound Optimization and Prioritization.
$850,917Anna Upton · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase
$850,917Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
JHU- Optimal regimen development on a Ribosome inhibitor backbone.
$850,915Eric L Nuermberger · Global Alliance For Tb Drug Development · U19 · FY2022 · AI
Mechanism and Inhibition of HIV Reverse Transcriptase
$850,773Karen S Anderson · Yale University · R37 · FY2024 · AI